Plaintiffs Battle For Lead Role In Vytorin ERISA Suit
By Brendan Pierson ( July 1, 2008, 12:00 AM EDT) -- The lead plaintiffs in a shareholder lawsuit over Merck & Co. Inc.'s shelved Vioxx painkiller have asked to assume the role of lead plaintiff in a new proposed multidistrict litigation over allegations that the company covered up evidence that its cholesterol drug Vytorin was less effective than advertised....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.